Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00561340 · ClinicalTrials.gov registry record · NA

Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication

A NA study of ADHD, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT00561340: Completed NA study of ADHD, sponsored by University of Nebraska.

NCT00561340 is a NA study of ADHD that has completed, run by University of Nebraska. The registered enrollment target is 29 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00561340, a NA study of ADHD, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if supplementing calories with Pediasure is effective in maintaining height, weight, and BMI percentiles for young children during 2 years of treatment with ADHD medication.

Primary Outcome

Change in weight observed from baseline to 6 months

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Pediasure
  • BEHAVIORAL Nutritional counseling

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center, Department of Psychiatry - Omaha

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2006-01-02
Est. Completion 2010-09-01
Phase NA
University of Nebraska

407 total trials

What the finished NCT00561340 record still lists

NCT00561340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (85% lower).

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Pediasure is the first listed.

NCT00561340 reports a single indexed study location in Nebraska.

Frequently Asked Questions

What is clinical trial NCT00561340 about?

NCT00561340 is a clinical study titled "Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication". The purpose of this study is to see if supplementing calories with Pediasure is effective in maintaining height, weight, and BMI percentiles for young children during 2 years of treatment with ADHD medication.

What is the current status of trial NCT00561340?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2006-01-02. Estimated completion is 2010-09-01.

What conditions does trial NCT00561340 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT00561340?

The interventions under investigation include: Pediasure (DIETARY_SUPPLEMENT), Nutritional counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT00561340?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00561340 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00561340's enrollment target sits among peer trials

29 63rd of 75 higher than 13 of 75 other ADHD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00561340, the US trial registry maintained by the National Library of Medicine. NCT00561340 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.